William Fairey - 18 Apr 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KALV	Stock Option (Right to Buy)	Award	$0	+17,000		$0.000000	17,000	18 Apr 2024	Common Stock	17,000	$11.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests over a 36 month period: 1/36th on May 18, 2024, after which 1/36th of the total shares vest monthly, subject to continued service through each vesting date.